Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for PLCO

Publication Year
Title PubMed Authors Journal Year Studies
Fine-mapping of genome-wide association study-identified risk loci for colorectal cancer in African Americans. 23851122 Wang H, Haiman CA, Burnett T, Fortini BK, Kolonel LN, Henderson BE, Signorello LB, Blot WJ, Keku TO, Berndt SI, Newcomb PA, Pande M, Amos CI, West DW, Casey G, Sandler RS, Haile R, Stram DO, Le Marchand L Hum. Mol. Genet. 2013 PLCO
Meta-analysis of gene-level associations for rare variants based on single-variant statistics. 23891470 Hu YJ, Berndt SI, Gustafsson S, Ganna A, Genetic Investigation of ANthropometric Traits (GIANT) Consortium, Hirschhorn J, North KE, Ingelsson E, Lin DY Am. J. Hum. Genet. 2013 PLCO
An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. 24058443 Klein AP, Lindström S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Lacroix A, Li D, Mandelson MT, Olson SH, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Zheng W, … PLoS ONE 2013 PLCO
Genome-wide association study identifies two susceptibility loci for osteosarcoma. 23727862 Savage SA, Mirabello L, Wang Z, Gastier-Foster JM, Gorlick R, Khanna C, Flanagan AM, Tirabosco R, Andrulis IL, Wunder JS, Gokgoz N, Patiño-Garcia A, Sierrasesúmaga L, Lecanda F, Kurucu N, Ilhan IE, Sari N, Serra M, Hattinger C, Picci P, Spector LG, … Nat. Genet. 2013 PLCO
A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma. 23814017 Purdue MP, Hofmann JN, Kemp TJ, Chaturvedi AK, Lan Q, Park JH, Pfeiffer RM, Hildesheim A, Pinto LA, Rothman N Blood 2013 PLCO
Circulating inflammation markers and prospective risk for lung cancer. 24249745 Shiels MS, Pfeiffer RM, Hildesheim A, Engels EA, Kemp TJ, Park JH, Katki HA, Koshiol J, Shelton G, Caporaso NE, Pinto LA, Chaturvedi AK J. Natl. Cancer Inst. 2013 PLCO
Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk. 23903690 Safaeian M, Rajaraman P, Hartge P, Yeager M, Linet M, Butler MA, Ruder AM, Purdue MP, Hsing A, Beane-Freeman L, Hoppin JA, Albanes D, Weinstein SJ, Inskip PD, Brenner A, Rothman N, Chatterjee N, Gillanders EM, Chanock SJ, Wang SS Cancer Causes Control 2013 PLCO
Hormonal risk factors and invasive epithelial ovarian cancer risk by parity. 23820255 Bodelon C, Wentzensen N, Schonfeld SJ, Visvanathan K, Hartge P, Park Y, Pfeiffer RM Br. J. Cancer 2013 PLCO
Metabolomics in epidemiology: sources of variability in metabolite measurements and implications. 23396963 Sampson JN, Boca SM, Shu XO, Stolzenberg-Solomon RZ, Matthews CE, Hsing AW, Tan YT, Ji BT, Chow WH, Cai Q, Liu DK, Yang G, Xiang YB, Zheng W, Sinha R, Cross AJ, Moore SC Cancer Epidemiol. Biomarkers Prev. 2013 PLCO
Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study. 23115063 Melin B, Dahlin AM, Andersson U, Wang Z, Henriksson R, Hallmans G, Bondy ML, Johansen C, Feychting M, Ahlbom A, Kitahara CM, Wang SS, Ruder AM, Carreón T, Butler MA, Inskip PD, Purdue M, Hsing AW, Mechanic L, Gillanders E, Yeager M, Linet M, Chanock… Int. J. Cancer 2013 PLCO
Fruit and vegetable intake and risk of breast cancer by hormone receptor status. 23349252 Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Cerhan JR, Gaudet MM, Giles GG, Goodman G, Hakansson N, Hankinson SE, Helzlsouer K, Horn-Ross PL, Inoue M, Krogh V, Lof M, McCullough ML, Miller AB, Neuhouser ML… J. Natl. Cancer Inst. 2013 PLCO
A prospective study of leukocyte telomere length and risk of renal cell carcinoma. 23513041 Hofmann JN, Lan Q, Cawthon R, Hosgood HD, Shuch B, Moore LE, Rothman N, Chow WH, Purdue MP Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 PLCO
Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. 23698636 Koutros S, Meyer TE, Fox SD, Issaq HJ, Veenstra TD, Huang WY, Yu K, Albanes D, Chu LW, Andriole G, Hoover RN, Hsing AW, Berndt SI Carcinogenesis 2013 PLCO
Genetic variation in the base excision repair pathway, environmental risk factors, and colorectal adenoma risk. 23951112 Corral R, Lewinger JP, Joshi AD, Levine AJ, Vandenberg DJ, Haile RW, Stern MC PLoS One 2013 PLCO
Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer. 22546513 Lavender NA, Rogers EN, Yeyeodu S, Rudd J, Hu T, Zhang J, Brock GN, Kimbro KS, Moore JH, Hein DW, Kidd LC BMC Med Genomics 2012 PLCO
Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. 22429766 Sutcliffe S, Grubb Iii RL, Platz EA, Ragard LR, Riley TL, Kazin SS, Hayes RB, Hsing AW, Andriole GL, Urologic Diseases in America Project BJU Int. 2012 PLCO
Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. 22162237 Anderson KE, Mongin SJ, Sinha R, Stolzenberg-Solomon R, Gross MD, Ziegler RG, Mabie JE, Risch A, Kazin SS, Church TR Mol. Carcinog. 2012 PLCO
Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma. 21932422 Gao Y, Katki H, Graubard B, Pollak M, Martin M, Tao Y, Schoen RE, Church T, Hayes RB, Greene MH, Berndt SI Int. J. Cancer 2012 PLCO
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. 22228146 Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan… J. Natl. Cancer Inst. 2012 PLCO
Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer. 22198243 Xu JL, Commins J, Partridge E, Riley TL, Prorok PC, Johnson CC, Buys SS Gynecol. Oncol. 2012 PLCO